- Home
- MARPS vs AIMD Comparison
MARPS vs AIMD Comparison
Compare MARPS & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MARPS | AIMD |
|---|---|---|
| Founded | 1956 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0M | 10.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MARPS | AIMD |
|---|---|---|
| Price | $4.38 | $1.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.3K | ★ 1.9M |
| Earning Date | 02-13-2026 | 03-06-2026 |
| Dividend Yield | ★ 8.27% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $965,040.00 | $113,037.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.39 | ★ N/A |
| Revenue Growth | N/A | ★ 178.19 |
| 52 Week Low | $3.34 | $1.54 |
| 52 Week High | $7.90 | $4.50 |
Technical Indicators
Market Signals| Indicator | MARPS | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.78 | 37.38 |
| Support Level | $4.44 | $1.54 |
| Resistance Level | $5.21 | $2.45 |
| Average True Range (ATR) | 0.31 | 0.25 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 1.06 | 5.43 |
Price Performance
Historical ComparisonAbout MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About AIMD Ainos Inc.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.